{"id":"daivobet-gel","safety":{"commonSideEffects":[{"rate":null,"effect":"Application site irritation"},{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Folliculitis"},{"rate":null,"effect":"Hypercalcemia (with extensive use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcipotriene acts as a vitamin D receptor agonist that regulates keratinocyte proliferation and differentiation, while betamethasone dipropionate is a potent topical corticosteroid that suppresses inflammatory cytokines and immune cell infiltration. Together, they provide synergistic anti-inflammatory and anti-proliferative effects on psoriatic plaques.","oneSentence":"Daivobet combines calcipotriene (a vitamin D analog) and betamethasone dipropionate (a corticosteroid) to reduce inflammation and normalize skin cell differentiation in psoriasis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:08:40.340Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Plaque psoriasis (topical treatment)"}]},"trialDetails":[{"nctId":"NCT01120223","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-05","conditions":"Scalp Psoriasis","enrollment":78},{"nctId":"NCT01083758","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Scalp Psoriasis","enrollment":31},{"nctId":"NCT01607853","phase":"PHASE2","title":"A Short-contact Plaque Test Study With Daivobet® Gel in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-06","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT02310646","phase":"PHASE3","title":"Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Psoriasis Vulgaris","enrollment":219},{"nctId":"NCT02668692","phase":"PHASE3","title":"LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-02","conditions":"Psoriasis Vulgaris","enrollment":213},{"nctId":"NCT01837576","phase":"PHASE1","title":"An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT02416258","phase":"PHASE2","title":"A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-04","conditions":"Skin and Connective Tissue Diseases","enrollment":50},{"nctId":"NCT01229098","phase":"PHASE2","title":"Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-10","conditions":"Psoriasis Vulgaris","enrollment":102},{"nctId":"NCT02636101","phase":"","title":"Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-01","conditions":"Psoriasis Vulgaris","enrollment":603},{"nctId":"NCT01707368","phase":"","title":"Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2012-10","conditions":"Psoriasis Vulgaris, Plaque Psoriasis","enrollment":561},{"nctId":"NCT02856542","phase":"","title":"Real-life Evaluation of the Daivobet® Gel Applicator","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-05-23","conditions":"Plaque Psoriasis","enrollment":1560},{"nctId":"NCT02999776","phase":"PHASE1","title":"Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis","status":"UNKNOWN","sponsor":"Pantec Biosolutions AG","startDate":"2016-11","conditions":"Psoriatic Plaque","enrollment":30},{"nctId":"NCT01587755","phase":"PHASE4","title":"Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP)","status":"COMPLETED","sponsor":"Kristian Reich, MD","startDate":"2012-03","conditions":"Mild to Moderate Psoriasis","enrollment":1852},{"nctId":"NCT01320774","phase":"","title":"Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-04","conditions":"Psoriasis Vulgaris","enrollment":588}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":16,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Taclonex® ointment","Calcipotriol","Betamethasone dipropionate"],"phase":"phase_3","status":"active","brandName":"Daivobet® gel","genericName":"Daivobet® gel","companyName":"LEO Pharma","companyId":"leo-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Daivobet combines calcipotriene (a vitamin D analog) and betamethasone dipropionate (a corticosteroid) to reduce inflammation and normalize skin cell differentiation in psoriasis. Used for Plaque psoriasis (topical treatment).","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-06-26T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"NDA019137"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-06-26T00:00:00.000Z","mah":"SAVAGE LABS","brand_name_local":"ALPHATREX","application_number":"NDA019138"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-09-04T00:00:00.000Z","mah":"SAVAGE LABS","brand_name_local":"ALPHATREX","application_number":"NDA019143"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-09-04T00:00:00.000Z","mah":"FOUGERA PHARMS INC","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"NDA019141"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1985-07-31T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA070281"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-02-03T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071012"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-02-03T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA070885"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-04-27T00:00:00.000Z","mah":"ORGANON","brand_name_local":"DIPROLENE AF","application_number":"NDA019555"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-06-17T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071143"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-08-10T00:00:00.000Z","mah":"TEVA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071477"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-08-10T00:00:00.000Z","mah":"TEVA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071476"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1987-08-10T00:00:00.000Z","mah":"COSETTE","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071467"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1988-06-06T00:00:00.000Z","mah":"COSETTE","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071882"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1988-08-24T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA072276"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1990-01-31T00:00:00.000Z","mah":"PADAGIS US","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA072538"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1992-04-30T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA073552"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1994-09-15T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA074271"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1994-09-30T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA074272"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1995-08-31T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA074304"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1997-11-26T00:00:00.000Z","mah":"PERRIGO NEW YORK","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA074579"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1999-06-22T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA075373"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2000-12-08T00:00:00.000Z","mah":"MERCK SHARP DOHME","brand_name_local":"LOTRISONE","application_number":"NDA020010"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2001-05-29T00:00:00.000Z","mah":"TARO","brand_name_local":"CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE","application_number":"ANDA075673"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2001-06-05T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE","application_number":"ANDA075502"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-05-13T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA075276"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-12-02T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076508"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-12-09T00:00:00.000Z","mah":"PADAGIS ISRAEL","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076592"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-12-09T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076543"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2003-12-09T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076215"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2004-01-23T00:00:00.000Z","mah":"CHARTWELL MOLECULAR","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076603"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2004-07-28T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE","application_number":"ANDA076493"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2004-10-12T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA076753"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2005-06-16T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE","application_number":"ANDA076516"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2007-05-21T00:00:00.000Z","mah":"FOUGERA PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA077111"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2007-05-21T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA077477"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2008-09-23T00:00:00.000Z","mah":"GLENMARK PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA078930"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-10-30T00:00:00.000Z","mah":"GLENMARK SPECLT","brand_name_local":"CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE","application_number":"ANDA202894"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2016-02-05T00:00:00.000Z","mah":"PRIMUS PHARMS","brand_name_local":"SERNIVO","application_number":"NDA208079"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-11-09T00:00:00.000Z","mah":"PADAGIS US","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA206118"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-02-06T00:00:00.000Z","mah":"HIKMA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA209896"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-02-13T00:00:00.000Z","mah":"ENCUBE","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA206389"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-10-12T00:00:00.000Z","mah":"COSETTE","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA210217"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2019-12-18T00:00:00.000Z","mah":"LUPIN","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA209106"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-06-17T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA211722"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-07-14T00:00:00.000Z","mah":"ZYDUS LIFESCIENCES","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA214048"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-09-11T00:00:00.000Z","mah":"PADAGIS ISRAEL","brand_name_local":"CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE","application_number":"ANDA212367"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-02-18T00:00:00.000Z","mah":"TP ANDA HOLDINGS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA215186"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-04-12T00:00:00.000Z","mah":"PADAGIS ISRAEL","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA215847"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-04-10T00:00:00.000Z","mah":"AUROBINDO PHARMA LTD","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA218289"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2026-01-26T00:00:00.000Z","mah":"AUROBINDO PHARMA LTD","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA219348"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PHARMADERM","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"NDA019136"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PERRIGO NEW YORK","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA072536"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PERRIGO NEW YORK","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA072526"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"ALPHARMA US PHARMS","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"ANDA071085"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PHARMADERM","brand_name_local":"BETAMETHASONE DIPROPIONATE","application_number":"NDA019140"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}